PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition
Science Advances · 2023
DOI: 10.1126/sciadv.ade8641 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Joanna Triscott und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department for BioMedical Research, University of Bern, Bern 3008, Switzerland. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Castration-Resistant, Receptors, Androgen. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Phosphatidylinositol (PI)regulating enzymes are frequently altered in cancer and have become a focus for drug development. Here, we explore the phosphatidylinositol-5-phosphate 4-kinases (PI5P4K), a family of lipid kinases that regulate pools of intracellular PI, and demonstrate that the PI5P4Kα isoform influences androgen receptor (AR) signaling, which supports prostate cancer (PCa) cell survival. The regulation of PI becomes increasingly important in the setting of metabolic stress adaptation of PCa during androgen deprivation (AD), as we show that AD influences PI abundance and enhances intracellular pools of PI-4,5-P 2 . We suggest that this PI5P4Kα-AR relationship is mitigated through mTORC1 dysregulation and show that PI5P4Kα colocalizes to the lysosome, the intracellular site of mTORC1 complex activation. Notably, this relationship becomes prominent in mouse prostate tissue following surgical castration. Finally, multiple PCa cell models demonstrate marked survival vulnerability following stable PI5P4Kα inhibition. These results nominate PI5P4Kα as a target to disrupt PCa metabolic adaptation to castrate resistance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department for BioMedical Research, University of Bern, Bern 3008, Switzerland.
- Institute of Biosciences, São Paulo State University, São Paulo, Brazil.
- Visceral Surgery and Precision Medicine Research Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.
- Cell and Molecular Biology of Cancer Program, Sanford Burnham Prebys, La Jolla, CA 92037, USA.
- COMPATH, Institute of Animal Pathology, University of Bern, Bern, Switzerland.
- Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY 10065, USA.
ORCID-Profile: Joanna Triscott, Matthias Reist, Lukas Küng, Francielle C Mosele, John Gallon, Simone de Brot, Mark Lundquist, Hector Gallart-Ayala, Julijana Ivanisevic, Salvatore Piscuoglio, Lewis C Cantley, Brooke M Emerling, Mark A Rubin
Förderung
- NCI NIH HHS
Zitieren
APA
Triscott, J., Reist, M., Küng, L., Mosele, F. C., Lehner, M., Gallon, J., Ravi, A., Arora, G. K., de Brot, S., Lundquist, M., Gallart-Ayala, H., Ivanisevic, J., Piscuoglio, S., Cantley, L. C., Emerling, B. M., & Rubin, M. A. (2023). PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition. Science Advances. https://doi.org/10.1126/sciadv.ade8641
Vancouver
Triscott J, Reist M, Küng L, Mosele FC, Lehner M, Gallon J, et al. PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition. Science Advances. 2023. doi:10.1126/sciadv.ade8641
BibTeX
@article{Triscott2023,
author = {Triscott, Joanna and Reist, Matthias and Küng, Lukas and Mosele, Francielle C and Lehner, Marika and Gallon, John and Ravi, Archna and Arora, Gurpreet K and de Brot, Simone and Lundquist, Mark and Gallart-Ayala, Hector and Ivanisevic, Julijana and Piscuoglio, Salvatore and Cantley, Lewis C and Emerling, Brooke M and Rubin, Mark A},
title = {PI5P4Kα supports prostate cancer metabolism and exposes a survival vulnerability during androgen receptor inhibition},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.ade8641}
}
EUVIMED